CIK 0001178670
- Large accelerated filer
ALNYLAM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ALNY
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 770602661
- Phone
- +1 617-551-8200
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142
- Former names
- ALNYLAM PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $543,126
- in 2 filings
- Open-market sales, last 90 days
- $398,855
- in 1 filing
Net +$144,271. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-26 | Poulton Jeffrey V. EVP, Chief Financial Officer | Grant or award | +3,277 | 12,683 | ||
| 2023-04-26 | Tanguler Tolga EVP, Chief Commercial Officer | Grant or award | +3,277 | 3,277 | ||
| 2023-04-26 | Vaishnaw Akshay President | Grant or award | +5,312 | 20,282 | ||
| 2023-04-26 | Garg Pushkal CMO & EVP Dev & Med Affairs | Grant or award | +4,294 | 8,639 | ||
| 2023-04-06 | Franchini Indrani Lall EVP, CLO & Secretary | Sale | −3,500 | $210.00 | $735K | 0 |
| 2023-03-07 | KELLOGG PETER N Director | Grant or award · Stock Option (right to buy) | +4,948 | 4,948 | ||
| 2023-03-03 | Garg Pushkal CMO & EVP Dev & Med Affairs | Exercise or conversion | +2,500 | $96.45 | $241K | 19,917 |
| 2023-03-03 | Garg Pushkal CMO & EVP Dev & Med Affairs | Exercise or conversion | +2,500 | $96.45 | $241K | 22,417 |
| 2023-03-03 | Garg Pushkal CMO & EVP Dev & Med Affairs | Sale | −18,072 | $200.00 | $3.6M | 4,345 |
| 2023-03-03 | Garg Pushkal CMO & EVP Dev & Med Affairs | Exercise or conversion · Performance Stock Option 2014 (right to buy) | −2,500 | 0 | ||
| 2023-03-03 | Garg Pushkal CMO & EVP Dev & Med Affairs | Exercise or conversion · Stock Option (right to buy) | −2,500 | 0 | ||
| 2023-02-27 | Greenstreet Yvonne Chief Executive Officer | Grant or award · Restricted Stock Units | +17,763 | 17,763 | ||
| 2023-02-27 | Greenstreet Yvonne Chief Executive Officer | Grant or award · Stock Option (right to buy) | +36,775 | 36,775 | ||
| 2023-02-27 | Vaishnaw Akshay President | Grant or award · Restricted Stock Units | +5,790 | 5,790 | ||
| 2023-02-27 | Vaishnaw Akshay President | Grant or award · Stock Option (right to buy) | +11,986 | 11,986 | ||
| 2023-02-27 | Garg Pushkal CMO & EVP Dev & Med Affairs | Grant or award · Restricted Stock Units | +5,724 | 5,724 | ||
| 2023-02-27 | Garg Pushkal CMO & EVP Dev & Med Affairs | Grant or award · Stock Option (right to buy) | +11,850 | 11,850 | ||
| 2023-02-27 | Poulton Jeffrey V. EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +5,724 | 5,724 | ||
| 2023-02-27 | Poulton Jeffrey V. EVP, Chief Financial Officer | Grant or award · Stock Option (right to buy) | +11,850 | 11,850 | ||
| 2023-02-27 | Tanguler Tolga EVP, Chief Commercial Officer | Grant or award · Restricted Stock Units | +5,000 | 5,000 |
Page 56 of 63 · 1,253 trades